Please provide your email address to receive an email when new articles are posted on . Age, nulliparity, polyps and shorter sampling intervals may predict endometrial hyperplasia and cancer. Risk ...
Relative conditional survival in 41,476 patients with ovarian cancer. Oxaliplatin plus continuous infusion topotecan: An ongoing phase II study for recurrent ovarian cancer—A New York Cancer ...
How would you proceed with a 64-year-old woman who has complex endometrial hyperplasia and secretory changes? The patient is not receiving hormone replacement therapy, and her follicle-stimulating ...
Please provide your email address to receive an email when new articles are posted on . Treatment with a levonorgestrel-dispensing intrauterine device appeared to be effective and safe for women with ...
Reproductive and Sexual Function After Platinum-Based Chemotherapy in Long-Term Ovarian Germ Cell Tumor Survivors: A Gynecologic Oncology Group Study This multicenter prospective study was carried out ...
Hormonal therapy with an intrauterine device (IUD) led to complete tumor regression in two-thirds of women with early-stage endometrial cancer or precancerous lesions, a randomized pragmatic phase II ...
Hosted on MSN
Bayer’s New Study on Mirena: A Potential Game-Changer for Endometrial Hyperplasia Treatment
Bayer AG ((BAYRY)) announced an update on their ongoing clinical study. Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to ...
Uterine cancer is the fourth most common cancer among women and the most common cancer of a woman's reproductive system. There are two major types of uterine cancer: Adenocarcinoma of the endometrium: ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results